Measuring tumor cell proliferation with18f-flt pet during radiotherapy of esophageal squamous cell carcinoma: A pilot clinical study

Journal of Nuclear Medicine

Volumn 51, Issue 4, 2010, Pages 528-534

  Yue, Jinbo ^a   Chen, Lusheng ^a   Cabrera, Alvin R ^b   Sun, Xindong ^a   Zhao, Shuqiang ^a   Zheng, Fu ^a   Han, Anqin ^a   Zheng, Jinsong ^a   Teng, Xuezhong ^a   Li, Ma ^a   Ma, Yidong ^a   Han, Dali ^a   Zhao, Xianguang ^a   Mu, Dianbin ^a   Yu, Jinming ^a   Li, Yuhui ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Accelerated repopulation; Esophageal carcinoma; Radiotherapy

Indexed keywords

3' FLUOROTHYMIDINE F 18; CETUXIMAB; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; PACLITAXEL; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG UPTAKE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; TUMOR CELL; BONE MARROW CELL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS TUMOR; FEMALE; INFLAMMATION; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; RADIOGRAPHY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; DIDEOXYNUCLEOSIDES; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950922631     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.072124     Document Type: Article

References (23)

1. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623-1627.
2. Minsky BD, Pajak T, Ginsberg RJ, et al. INT 0123 (RTOG 94-05) phase III trial of combined modality therapy for esophageal cancer: high dose (64.8Gy) vs. standard dose (50.4Gy) radiation therapy. J Clin Oncol. 2004;22:45-52.
3. Kajanti M, Kaleta R, Kankaanranta L, Muhonen T, Holsti L. Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus. Int J Radiat Oncol Biol Phys. 1995;32:1017-1023.
4. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with F-18-FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
5. 18F-3-fluoro-3-deoxy-L- thymidine. Clin Cancer Res. 2004;10:1685-1690.
6. 18FDG uptake on PET with Ki-67 immunohisto-chemistry in non small lung cancer. Eur J Nucl Med Mol Imaging. 2007;34:1610-1616.
7. 18F-fluorodeoxyglucose positron emission tomography. Chest. 2006;129:393-401.
8. 18F]FLT uptake by positron emission tomography with Ki-67 immuno-histochemistry and flow cytometry in human lung tumours. Clin Cancer Res. 2002;8:3315-3323.
9. 18F]FLT). J Radioanal Nucl Chem. 2000;243:843-846.
10. 18F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys. 2009 [Epub ahead of print].
11. Withers HR, Taylor JM. Critical volume model. Int J Radiat Oncol Biol Phys. 1993;25:151-152.
12. Fowler JF. Rapid repopulation in radiotherapy: a debate on mechanism - the phantom of tumor treatment: continually rapid proliferation unmasked. Radiother Oncol. 1991;22:156-158.
13. Schmidt-Ullrich RK, Contessa JN, Dent P, et al. Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig. 1999;7:321-330. (Pubitemid 30033351)
14. 18F-FLT positron emission tomography/ computed tomography imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;75:1098-1104.
15. Zhao KL, Shi XH, Jiang GL, et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys. 2005;62:1014-1020.
16. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
17. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
18. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine 18-fluorodeoxyglucose uptake. J Nucl Med. 1994;35:104-112. (Pubitemid 24018451)
19. 18F-FDG. J Nucl Med. 2005;46:945-952.
20. Pio BS, Park CK, Pietras R, et al. Usefulness of 3′-[F-18]fluoro- 3′-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol. 2006;8:36-42.
21. 18F]fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging. 2007;34:1339-1347.
22. 18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma. Clin Cancer Res. 2007;13:3552-3558.
23. 18F]FLT uptake after chemotherapy: an experimental study. Eur J Nucl Med Mol Imaging. 2002;29:1462-1469.